24-Hour protein, arginine and citrulline metabolism in fed critically ill children - A stable isotope tracer study

Carlijn T I de Betue1, Xiomara C Garcia Casal2, Dick A van Waardenburg3

  • 1Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.

Insights

Stable isotope studies in critically ill children reveal high variability in amino acid appearance over 24 hours. This variability, not circadian rhythm, impacts protein and arginine metabolism assessments.

Area of Science:

  • Metabolic research in pediatric intensive care.
  • Nutritional science and amino acid metabolism.

Background:

  • Current methods for studying protein and arginine metabolism in critically ill children rely on short-term (4-8h) stable isotope measurements extrapolated to 24 hours.
  • This extrapolation may be inaccurate due to critical illness-related factors and potential circadian rhythms affecting 24-hour measurements.

Purpose of the Study:

  • To investigate the 24-hour appearance of specific amino acids (phenylalanine, tyrosine, leucine, arginine, citrulline) using stable isotope techniques in continuously fed critically ill children.
  • To assess the variability and potential circadian patterns in amino acid metabolism over a full 24-hour period.

Main Methods:

  • A 24-hour stable isotope tracer protocol was conducted in eight critically ill children (0-10 years) receiving continuous parenteral nutrition.
  • Intravenous and enteral stable isotopes of phenylalanine, tyrosine, leucine, arginine, and citrulline were infused, with hourly arterial blood sampling.
  • Protein intake ranged from 1.0-3.7 g/kg/day.

Main Results:

  • High coefficients of variation (14-26%) were observed for the 24-hour appearance of infused amino acids, indicating significant intra-individual variability.
  • No evident circadian rhythm was detected in the amino acid appearances.
  • The pattern and overall 24-hour level of whole-body protein balance varied considerably among individuals.

Conclusions:

  • Amino acid appearances in continuously fed, stable critically ill children exhibit substantial variability over 24 hours.
  • This high variability must be considered when designing and interpreting stable isotope studies in this patient population.
  • No apparent circadian rhythm influences these amino acid measurements in this context.
Abstract

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Urea Cycle01:23

Urea Cycle

The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
51.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
586
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
573